Cardiac Science to Present at the UBS Global Life Sciences Conference

Tuesday, September 18, 2007 General News J E 4
BOTHELL, Wash., Sept. 17 Cardiac ScienceCorporation (Nasdaq: CSCX), a global leader in advanced cardiac monitoring anddefibrillation products, announced today that it will present at the UBSGlobal Life Sciences Conference at the Grand Hyatt in New York City. TheCompany's presentation is scheduled for Monday, September 24, 2007 at 3:30 p.m.

Eastern Time. Michael Matysik, senior vice president and chief financialofficer, will review the Company's business strategy and recent financialresults.


Attendance at the conference is by invitation only. Cardiac Science willoffer a live audio webcast of its presentation, which may be accessed at theCompany's website at An archived replay of thepresentation will also be available following the live presentation and can beaccessed at

About Cardiac Science Corporation

Cardiac Science is truly at the heart of saving lives. The Companydevelops, manufactures, and markets a family of advanced diagnostic andtherapeutic cardiology devices and systems, including AEDs,electrocardiographs, stress test systems, Holter monitoring systems, hospitaldefibrillators, cardiac rehabilitation telemetry systems, patientmonitor - defibrillators and cardiology data management systems. CardiacScience also sells a variety of related products and consumables, and providesa comprehensive portfolio of training, maintenance and support services. TheCompany is the successor to various entities that have owned and operatedcardiology-related businesses that sold products under the trusted brand namesBurdick(R), Powerheart(R), and Quinton(R). Cardiac Science is headquartered inBothell, WA, and also has operations in Lake Forest, California; Deerfield,Wisconsin; Shanghai, China and Manchester, United Kingdom.Company Contact: Mike Matysik Cardiac Science Corporation Chief Financial Officer 425-402-2009 Investor Contact: EVC Group, Inc. Douglas Sherk/Jenifer Kirtland 415-896-6820 Media Contact: EVC Group, Inc. Steve DiMattia 646-201-5445

SOURCE Cardiac Science Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Young Children Thrive on 30,000 Words a Day
Genomic Health to Present at ThinkEquity Partners ...